Join the Botox Cosmetic group to help and get support from people like you.
Botox Cosmetic News
Botox Intervention Improves Facial Asymmetry After Nerve Damage
TUESDAY, March 18, 2025 – For patients with severe oral commissure droop from facial nerve damage undergoing surgery, botulinum toxin type A (BoNT-A) treatment helps to alleviate muscle...
One in Six Parents Support Teens Getting Nonsurgical Cosmetic Procedures
FRIDAY, Feb. 28, 2025 -- Few parents say their teen has asked about nonsurgical cosmetic procedures, according to the results of a C.S. Mott Children's Hospital National Poll on Children's Health ...
Should Your Teen Receive Non-Surgical Cosmetic Treatments?
THURSDAY, Feb. 20, 2025 – Social media often tempts teenagers with non-surgical ways to improve their appearance, such as laser hair removal, skin and teeth whitening, chemical peels, botox, and...
Monthly News Roundup - October 2024
FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev (foscarbidopa and foslevodopa) for the treatment of motor f...
Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ – Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Botox Cosmetic for temporary improvement in the appearance...
Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun Climate
FRIDAY, July 19, 2024 – To achieve maximal paralysis, patients injected with glabellar botulinum toxin may have significantly higher dose requirements in a high sun-exposure environment, according...
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections
FRIDAY, July 12, 2024 – Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of...
Fake Botox Shots Land 13 Women in Hospital
FRIDAY, July 12, 2024 – Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator, a new report warns. In...
Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine
THURSDAY, May 9, 2024 – Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May issue of Plastic...
FDA Medwatch Alert: Counterfeit Versions of Botox Found in Multiple States
April 16, 2024 -- FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states and administered to consumers ...
FDA Approves Botox Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines
DUBLIN, Oct. 3, 2017 /PRNewswire/ – Today Allergan plc (NYSE: AGN) announced the FDA approval of Botox Cosmetic for its third indication, the temporary improvement in the appearance of moderate to...
FDA Approves Botox Cosmetic to Improve the Appearance of Crow’s Feet Lines
WEDNESDAY, September 11, 2013 – The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to...
FDA Approves Botox to Treat Chronic Migraine
SILVER SPRING, Md., Oct. 15 – The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine...
FDA Medwatch Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen...
FDA Medwatch Alert: Botox, Botox Cosmetic (Botulinum toxin Type A), Myobloc (Botulinum toxin Type B)
[Posted 02/07/2008] FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic. FDA has received reports of systemic adverse reactions including respiratory...